Lilly Asia Ventures co-led the first round for the CNS disease drug developer, which is headed by one of its former venture partners.
Month: December 2020
Wicke promoted to head health initiative
Boehringer Ingelheim Venture Fund investment director will head health impact investment partnership Making More Health.
Gohenry waves through $40m
Citi Ventures participated in the first non-crowdfunded equity round to be disclosed by the kids’ finance management app developer.
Ro reels in Workpath
Heritage Group has exited Workpath, a developer of in-home care management software, through an acquisition by Ro.
Vigil emerges with $50m
Amgen is a shareholder of Vigil Neuroscience, which is developing microglia-based treatments for neurodegenerative diseases.
Cuemath counts on CapitalG for $40m series C
Alphabet unit CapitalG supplied $5m in a round representing the second time it has backed the online maths tutorial provider.
B Capital backs Centivo’s $34m series B
The B Capital Group-led round has helped the digital health insurance business take its overall funding to at least $68m since launch.
Luko cooks up $60m series B
The digital home insurance provider has secured funding in a round that included Orange’s corporate venture capital unit.
SunCulture cultivates $14m series A
EDF and Dream Project Incubators are investing in the Africa-based solar system provider, the former having launched a partnership with it two years ago.
Powerlist Q&A – Irene Gómez Luque, Telefónica Connected Open Innovation
Q&A with Irene Gómez, director, Telefónica Connected Open Innovation
Aurora drives $10bn Uber ATG merger
Uber’s autonomous driving spinoff, which had raised $1bn from SoftBank Vision Fund, Toyota and Denso, is merging with self-driving technology producer Aurora.
17EdTech secures $288m in initial public offering
The ByteDance-backed learning software and tutoring services provider priced its shares in the middle of their range as it went public in the US.
Pico picks out Intel for $135m series C
Intel Capital joined a range of investors for the financial markets IT provider that include financial services and trading firms.
BioAge reaches series C stage with $90m
Kaiser Foundation Hospitals helped anti-ageing therapy developer BioAge Labs increase its overall funding to $137m.